After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...

This year’s American Association of Cancer Research (AACR) annual meeting saw a clutch of new studies on therapeutic vaccines that suggest the approach is starting to gain traction, after years ...

Providers currently utilize shared decision-making to help individuals who have prostate cancer determine their course of treatment: active surveillance or definitive therapy. However, for individuals ...

Laser technology has rapidly propelled surgical techniques in urinary tract calculus removal. The thulium fiber laser (TFL) is a relatively new tool that can be used for laser lithotripsy, as an ...